Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04965818
Title Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

Binimetinib + Futibatinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.